NewVale Capital wraps up debut fund at $167m
The fund will accelerate the growth of pharmaceutical services companies.
13 May 2024•1 min read
The fund will accelerate the growth of pharmaceutical services companies.
Gainline Capital upsizes target for Fund III
22 October 2026 · 2 mins read
KKR’s Alisa Wood: PE isn’t worth it if you can’t access top GPs
21 October 2026 · 3 mins read
LACERA to reduce meeting frequency despite governance concerns
21 October 2026 · 3 mins read
Retiring SBCERA CIO leaves income-focused private markets playbook for successor
20 October 2026 · 3 mins read
Blackstone’s Foley on the speedy close of a fifth energy transition fund
20 October 2026 · 3 mins read
DOWNLOAD: Private equity fundraising stays on growth path despite Q3 dip
19 October 2026 · 2 mins read
The midterms’ message to the industry
16 October 2026 · 7 mins read
